Published in Eur J Cancer on December 09, 2005
A Program for Improved Family Screening for Colorectal Cancer (COLOR3) | NCT03620877
A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology (2008) 2.56
Pooled analysis of genetic variation at chromosome 8q24 and colorectal neoplasia risk. Hum Mol Genet (2008) 1.96
Population-based family history-specific risks for colorectal cancer: a constellation approach. Gastroenterology (2009) 1.61
Understanding the contribution of family history to colorectal cancer risk and its clinical implications: A state-of-the-science review. Cancer (2016) 1.55
Prevalence of any size adenomas and advanced adenomas in 40- to 49-year-old individuals undergoing screening colonoscopy because of a family history of colorectal carcinoma in a first-degree relative. Gastrointest Endosc (2011) 1.42
Meta-analyses of colorectal cancer risk factors. Cancer Causes Control (2013) 1.42
Incidence and Mortality of Colorectal Cancer in Individuals With a Family History of Colorectal Cancer. Gastroenterology (2015) 1.40
Prospective study of family history and colorectal cancer risk by tumor LINE-1 methylation level. J Natl Cancer Inst (2012) 1.24
Colonoscopy screening in African Americans and Whites with affected first-degree relatives. Arch Intern Med (2008) 1.13
How can polygenic inheritance be used in population screening for common diseases? Genet Med (2013) 1.10
Endoscopic tattooing of colorectal lesions: Is it a risk-free procedure? World J Gastrointest Endosc (2011) 1.05
Family history of colorectal cancer: a determinant of advanced adenoma stage or adenoma multiplicity? Int J Cancer (2009) 1.01
Family history and colorectal cancer survival in women. Fam Cancer (2008) 0.96
Association of familial colorectal cancer with variants in the E-cadherin (CDH1) and cyclin D1 (CCND1) genes. Int J Colorectal Dis (2007) 0.95
Family history influences the early onset of hepatocellular carcinoma. World J Gastroenterol (2012) 0.95
How much colonoscopy screening should be recommended to individuals with various degrees of family history of colorectal cancer? Cancer (2011) 0.93
Hereditary and common familial colorectal cancer: evidence for colorectal screening. Dig Dis Sci (2014) 0.92
Telehealth personalized cancer risk communication to motivate colonoscopy in relatives of patients with colorectal cancer: the family CARE Randomized controlled trial. J Clin Oncol (2014) 0.92
Cost-effectiveness of colorectal cancer screening in high-risk Spanish patients: use of a validated model to inform public policy. Cancer Epidemiol Biomarkers Prev (2010) 0.92
Multiplicity and molecular heterogeneity of colorectal carcinomas in individuals with serrated polyposis. Am J Surg Pathol (2013) 0.91
Development and validation of risk prediction algorithms to estimate future risk of common cancers in men and women: prospective cohort study. BMJ Open (2015) 0.91
Colonoscopy screening among US adults aged 40 or older with a family history of colorectal cancer. Prev Chronic Dis (2015) 0.89
Family history of colorectal cancer: clinicians' preventive recommendations and patient behavior. Prev Chronic Dis (2011) 0.89
Health behaviors and cancer screening among Californians with a family history of cancer. Genet Med (2012) 0.89
Cancer risks for the relatives of colorectal cancer cases with a methylated MLH1 promoter region: data from the Colorectal Cancer Family Registry. Cancer Prev Res (Phila) (2011) 0.88
Racial and ethnic variations in the effects of family history of colorectal cancer on screening compliance. Gastroenterology (2013) 0.86
Characteristics of Colorectal Cancer in Khorramabad, Iran during 2013. Middle East J Dig Dis (2014) 0.84
Risk perception among Brazilian individuals with high risk for colorectal cancer and colonoscopy. Hered Cancer Clin Pract (2011) 0.84
Determinants of participation in colonoscopic screening by siblings of colorectal cancer patients in France. BMC Cancer (2010) 0.82
MethyLight droplet digital PCR for detection and absolute quantification of infrequently methylated alleles. Epigenetics (2015) 0.82
Impact of a family history of colorectal cancer on the prevalence of advanced neoplasia at colonoscopy in 4,967 asymptomatic patients. Dig Dis Sci (2011) 0.82
Diagnostics and Epidemiology of Colorectal Cancer. Visc Med (2016) 0.81
Family history and the natural history of colorectal cancer: systematic review. Genet Med (2015) 0.80
Clinical relevance of 8q23, 15q13 and 18q21 SNP genotyping to evaluate colorectal cancer risk. Eur J Hum Genet (2015) 0.80
Screening patterns in patients with a family history of colorectal cancer often do not adhere to national guidelines. Dig Dis Sci (2013) 0.80
Colorectal cancer screening in patients at moderately increased risk due to family history. World J Gastrointest Oncol (2012) 0.80
Targeting colorectal cancer stem cells using curcumin and curcumin analogues: insights into the mechanism of the therapeutic efficacy. Cancer Cell Int (2015) 0.79
Interactions among physicians, patients, and first-degree relatives in the familial screening of colorectal cancer in France. Patient Prefer Adherence (2008) 0.79
Risk of Colorectal Neoplasia in Individuals With Self-Reported Family History: A Prospective Colonoscopy Study from 16 Asia-Pacific Regions. Am J Gastroenterol (2016) 0.78
Association of Nonsteroidal Anti-Inflammatory Drugs with Colorectal Cancer by Subgroups in the VITamins and Lifestyle (VITAL) Study. Cancer Epidemiol Biomarkers Prev (2015) 0.77
Colorectal cancer risk assessment and screening recommendation: a community survey of healthcare providers' practice from a patient perspective. BMC Fam Pract (2012) 0.77
Familial colorectal cancer: a review. World J Gastroenterol (2014) 0.77
Do individuals with a family history of colorectal cancer adhere to medical recommendations for the prevention of colorectal cancer? Fam Cancer (2013) 0.77
Familial colorectal cancer screening: When and what to do? World J Gastroenterol (2015) 0.77
Serum sCD26 for colorectal cancer screening in family-risk individuals: comparison with faecal immunochemical test. Br J Cancer (2014) 0.76
Positive family history of colorectal cancer in a general practice setting [FRIDA.Frankfurt]: study protocol of a of a cross-sectional study. BMC Cancer (2015) 0.75
Colonoscopy uptake for high-risk individuals with a family history of colorectal neoplasia: A multicenter, randomized trial of tailored counseling versus standard information. Medicine (Baltimore) (2016) 0.75
Decentralized colonoscopic surveillance with high patient compliance prevents hereditary and familial colorectal cancer. Fam Cancer (2016) 0.75
Randomized trial to increase colorectal cancer screening in an ethnically diverse sample of first-degree relatives. Cancer (2015) 0.75
Risk of Advanced Neoplasia in First-Degree Relatives with Colorectal Cancer: A Large Multicenter Cross-Sectional Study. PLoS Med (2016) 0.75
The correlation of major risk factors and clinicopathological characteristics in colorectal cancer patients under the age of 50. Int J Colorectal Dis (2015) 0.75
Family history of colorectal cancer and its impact on survival in patients with resected stage III colon cancer: results from NCCTG Trial N0147 (Alliance). J Gastrointest Oncol (2017) 0.75
The impact of family history on the risk of colorectal neoplasia: don't change the guidelines just yet! Dig Dis Sci (2012) 0.75
Differences in response to a dietary intervention between the general population and first-degree relatives of colorectal cancer patients. J Nutr Educ Behav (2014) 0.75
Rectal cancer: a review. Med J Islam Repub Iran (2015) 0.75
Knowledge acquired, satisfaction attained and attitudes towards shared decision making in colorectal cancer screening. Ann Gastroenterol (2016) 0.75
Accuracy of Colon Capsule Endoscopy in Detecting Colorectal Polyps in Individuals with Familial Colorectal Cancer: Could We Avoid Colonoscopies? Gastroenterol Res Pract (2017) 0.75
The impact of stratifying by family history in colorectal cancer screening programs. Int J Cancer (2015) 0.75
Impact of Fecal Hb Levels on Advanced Neoplasia Detection and the Diagnostic Miss Rate For Colorectal Cancer Screening in High-Risk vs. Average-Risk Subjects: a Multi-Center Study. Clin Transl Gastroenterol (2017) 0.75
Survival in familial colorectal cancer: a Danish cohort study. Fam Cancer (2015) 0.75
Genetic polymorphisms of NFκB1-94ins/delATTG and NFκBIA-881A/G genes in Egyptian patients with colorectal cancer. Fam Cancer (2017) 0.75
Comparison of the efficiency of colorectal cancer screening programs based on age and genetic risk for reduction of colorectal cancer mortality. Eur J Hum Genet (2017) 0.75
CT Colonographic Screening of Patients With a Family History of Colorectal Cancer: Comparison With Adults at Average Risk and Implications for Guidelines. AJR Am J Roentgenol (2017) 0.75
How should meta-regression analyses be undertaken and interpreted? Stat Med (2002) 8.96
Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography. Int J Epidemiol (2007) 7.00
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ (2011) 6.80
A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3. Nat Genet (2008) 6.26
Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol (2007) 4.96
Evaluation of networks of randomized trials. Stat Methods Med Res (2007) 4.70
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst (2010) 4.54
Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst (2002) 4.43
Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med (2008) 4.34
Interpretation of random effects meta-analyses. BMJ (2011) 4.32
Meta-analyses involving cross-over trials: methodological issues. Int J Epidemiol (2002) 4.30
Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33. Nat Genet (2010) 4.20
Safety and effectiveness of recombinant human bone morphogenetic protein-2 for spinal fusion: a meta-analysis of individual-participant data. Ann Intern Med (2013) 4.02
Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. JAMA (2007) 3.62
Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review. BMJ (2006) 3.47
Acceptability and accuracy of a non-endoscopic screening test for Barrett's oesophagus in primary care: cohort study. BMJ (2010) 3.44
Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies. Nat Genet (2010) 3.37
A road map for efficient and reliable human genome epidemiology. Nat Genet (2006) 3.21
Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk. Nat Genet (2012) 3.19
Meta-analysis of individual patient data from randomized trials: a review of methods used in practice. Clin Trials (2005) 3.19
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat Genet (2011) 3.07
Cell type-specific DNA methylation patterns in the human breast. Proc Natl Acad Sci U S A (2008) 2.99
Recent developments in meta-analysis. Stat Med (2008) 2.97
Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1. Nat Genet (2005) 2.92
Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls. Lancet (2006) 2.72
Graphical tools for network meta-analysis in STATA. PLoS One (2013) 2.66
Synthesizing evidence on complex interventions: how meta-analytical, qualitative, and mixed-method approaches can contribute. J Clin Epidemiol (2013) 2.59
Multiple common susceptibility variants near BMP pathway loci GREM1, BMP4, and BMP2 explain part of the missing heritability of colorectal cancer. PLoS Genet (2011) 2.47
A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum Mol Genet (2012) 2.45
Strengthening the reporting of genetic association studies (STREGA): an extension of the strengthening the reporting of observational studies in epidemiology (STROBE) statement. J Clin Epidemiol (2009) 2.45
STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement. PLoS Med (2009) 2.39
A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology (2003) 2.39
A case study of multiple-treatments meta-analysis demonstrates that covariates should be considered. J Clin Epidemiol (2009) 2.26
Pathology of ovarian cancers in BRCA1 and BRCA2 carriers. Clin Cancer Res (2004) 2.17
Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases. Am J Epidemiol (2009) 2.15
Treating individuals 4: can meta-analysis help target interventions at individuals most likely to benefit? Lancet (2005) 2.09
Array CGH in patients with learning disability (mental retardation) and congenital anomalies: updated systematic review and meta-analysis of 19 studies and 13,926 subjects. Genet Med (2009) 2.09
Predictive markers of anthracycline benefit: a prospectively planned analysis of the UK National Epirubicin Adjuvant Trial (NEAT/BR9601). Lancet Oncol (2010) 2.01
Risk factors for breast cancer: a reanalysis of two case-control studies from 1926 and 1931. Epidemiology (2010) 1.98
Characteristics of meta-analyses and their component studies in the Cochrane Database of Systematic Reviews: a cross-sectional, descriptive analysis. BMC Med Res Methodol (2011) 1.97
Conceptual and technical challenges in network meta-analysis. Ann Intern Med (2013) 1.92
Incorporating genomics into breast and prostate cancer screening: assessing the implications. Genet Med (2013) 1.91
STrengthening the REporting of Genetic Association studies (STREGA)--an extension of the STROBE statement. Eur J Clin Invest (2009) 1.82
Public health implications from COGS and potential for risk stratification and screening. Nat Genet (2013) 1.79
Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression. Hum Mol Genet (2013) 1.78
Evaluation of inconsistency in networks of interventions. Int J Epidemiol (2013) 1.72
Obstacles and opportunities in meta-analysis of genetic association studies. Genet Med (2005) 1.71
Seven lipoprotein lipase gene polymorphisms, lipid fractions, and coronary disease: a HuGE association review and meta-analysis. Am J Epidemiol (2008) 1.71
Genetic variation in the HSD17B1 gene and risk of prostate cancer. PLoS Genet (2005) 1.67
Common breast cancer susceptibility loci are associated with triple-negative breast cancer. Cancer Res (2011) 1.65
Assessing the impact of drinking water and sanitation on diarrhoeal disease in low- and middle-income settings: systematic review and meta-regression. Trop Med Int Health (2014) 1.64
Hygiene and health: systematic review of handwashing practices worldwide and update of health effects. Trop Med Int Health (2014) 1.63
The emergence of networks in human genome epidemiology: challenges and opportunities. Epidemiology (2007) 1.61
Systematic reviews of genetic association studies. Human Genome Epidemiology Network. PLoS Med (2009) 1.60
Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening. J Pathol (2004) 1.59
Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. Hum Mol Genet (2011) 1.56
Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42,103 individuals. Gut (2012) 1.52
Prediction of pathogenic mutations in patients with early-onset breast cancer by family history. Lancet (2003) 1.52
Common germline genetic variation in antioxidant defense genes and survival after diagnosis of breast cancer. J Clin Oncol (2007) 1.51
The association between the peroxisome proliferator-activated receptor-gamma2 (PPARG2) Pro12Ala gene variant and type 2 diabetes mellitus: a HuGE review and meta-analysis. Am J Epidemiol (2010) 1.49
Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE Statement. Hum Genet (2009) 1.47
Verbal autopsy: reliability and validity estimates for causes of death in the Golestan Cohort Study in Iran. PLoS One (2010) 1.47
Endometrial cancer and genetic variation in PTEN, PIK3CA, AKT1, MLH1, and MSH2 within a population-based case-control study. Gynecol Oncol (2010) 1.47
A network of investigator networks in human genome epidemiology. Am J Epidemiol (2005) 1.43
Lack of evidence for the efficacy of memantine in mild Alzheimer disease. Arch Neurol (2011) 1.42
Biases in Randomized Trials: A Conversation Between Trialists and Epidemiologists. Epidemiology (2017) 1.38
Portion, package or tableware size for changing selection and consumption of food, alcohol and tobacco. Cochrane Database Syst Rev (2015) 1.37
Evaluation of the Cochrane Collaboration's tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation. Syst Rev (2014) 1.36
Five glutathione s-transferase gene variants in 23,452 cases of lung cancer and 30,397 controls: meta-analysis of 130 studies. PLoS Med (2006) 1.35
Role of genetic polymorphisms and ovarian cancer susceptibility. Mol Oncol (2009) 1.33
The impact of study size on meta-analyses: examination of underpowered studies in Cochrane reviews. PLoS One (2013) 1.32
CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer. J Clin Oncol (2012) 1.29
Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE statement. Eur J Epidemiol (2009) 1.25
BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives. Eur J Cancer (2006) 1.24
Estimating within-study covariances in multivariate meta-analysis with multiple outcomes. Stat Med (2012) 1.23
TGFβ induces the formation of tumour-initiating cells in claudinlow breast cancer. Nat Commun (2012) 1.23
A design-by-treatment interaction model for network meta-analysis with random inconsistency effects. Stat Med (2014) 1.21
Identification and validation of prognostic markers in breast cancer with the complementary use of array-CGH and tissue microarrays. J Pathol (2005) 1.19
Diabetes mellitus and its correlates in an Iranian adult population. PLoS One (2011) 1.19
Molecular pathology in epidemiologic studies: a primer on key considerations. Cancer Epidemiol Biomarkers Prev (2010) 1.14
STrengthening the REporting of Genetic Association Studies (STREGA)--an extension of the STROBE statement. Genet Epidemiol (2009) 1.13
Biological and prognostic associations of miR-205 and let-7b in breast cancer revealed by in situ hybridization analysis of micro-RNA expression in arrays of archival tumour tissue. J Pathol (2012) 1.12
STrengthening the REporting of Genetic Association studies (STREGA): an extension of the STROBE Statement. Ann Intern Med (2009) 1.11
Allowing for uncertainty due to missing data in meta-analysis--part 1: two-stage methods. Stat Med (2008) 1.10
Challenges in the use of literature-based meta-analysis to examine gene-environment interactions. Am J Epidemiol (2010) 1.10
Bayesian meta-analysis and meta-regression for gene-disease associations and deviations from Hardy-Weinberg equilibrium. Stat Med (2007) 1.09
Bayesian multivariate meta-analysis with multiple outcomes. Stat Med (2013) 1.08
Refinement of the associations between risk of colorectal cancer and polymorphisms on chromosomes 1q41 and 12q13.13. Hum Mol Genet (2011) 1.07
Planning future studies based on the conditional power of a meta-analysis. Stat Med (2012) 1.05
Shorter telomere length is associated with increased ovarian cancer risk in both familial and sporadic cases. J Med Genet (2012) 1.04
A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age. Cancer Epidemiol Biomarkers Prev (2014) 1.03
Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer. Cancer Epidemiol Biomarkers Prev (2013) 1.02
Role of CHEK2*1100delC in unselected series of non-BRCA1/2 male breast cancers. Int J Cancer (2004) 1.01
Graphical augmentations to the funnel plot assess the impact of additional evidence on a meta-analysis. J Clin Epidemiol (2012) 1.01
Turning the pump handle: evolving methods for integrating the evidence on gene-disease association. Am J Epidemiol (2007) 1.01
Haplotypes of the estrogen receptor beta gene and breast cancer risk. Int J Cancer (2008) 0.99
Predictive distributions for between-study heterogeneity and simple methods for their application in Bayesian meta-analysis. Stat Med (2014) 0.98
Genetic variation in SIPA1 in relation to breast cancer risk and survival after breast cancer diagnosis. Int J Cancer (2009) 0.98